COPD (Chronic obstructive Pulmonary disease), as a chronic respiratory disease, has one of the highest morbidity and mortality rates in the world, bringing a heavy burden to patients and society ‌. Early screening and diagnosis of COPD is of great significance for reducing the mortality rate of patients and improving the quality of life of patients. In order to promote the concept of early diagnosis and treatment, more medical institutions and medical personnel can be encouraged to pay attention to the early screening and diagnosis of COPD, so as to improve the diagnosis rate of COPD. The "Breathe with Fate" early diagnosis and treatment meeting of COPD hosted by Chengdu High-tech Medical Association was held on January 23, 2025.

The conference brought together experts, scholars and medical workers from the departments of respiratory medicine, critical care medicine, infection and other related fields to discuss the latest research results, clinical experience and technical methods related to diseases. The first line of basic drugs for COPD treatment and the ideal inhalation device were discussed.

The conference provides a platform for the majority of medical practitioners and scientific researchers to exchange academic research results. Adhering to the purpose of highlighting practicality, keeping up with the forefront and focusing on hot topics, the conference is conducive to promoting the academic development of respiratory medicine and is of great significance for promoting high-quality clinical research in the field of respiratory medicine.